Image 2_Serum creatinine-to-cystatin C ratio and 1-year mortality risk in advanced breast cancer patients: a multicenter retrospective cohort study.tif

Image 2_Serum creatinine-to-cystatin C ratio and 1-year mortality risk in advanced breast cancer patients: a multicenter retrospective cohort study.tif

Background<p>Muscle wasting and sarcopenia in advanced breast cancer correlates with poor outcomes. The serum creatinine-to-cystatin C ratio (CCR) is a potential muscle mass biomarker, but its prognostic value in advanced breast cancer is unclear.</p>Methods<p>This multicenter retr...

Descrición completa

Gardado en:
Detalles Bibliográficos
Autor Principal: Huijie Deng (5664421) (author)
Outros autores: Jiacheng Yang (4867897) (author), Guanyu Zheng (602277) (author), Biyao Zhang (3160059) (author), Yuzhou Wang (600730) (author), Yuye Wu (22381971) (author), Shufen Mo (21743543) (author), Shengchao Huang (22686392) (author), Yuanqi Zhang (18483375) (author), Lixia Li (407712) (author)
Publicado: 2025
Subjects:
Clinical and Sports Nutrition
breast cancer
creatinine
cystatin C
creatinine–cystatin C
muscle mass
sarcopenia
mortality
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares